This proposal is a continuation of a Merit Grant whose long-term objective has been the development of powerful analytical and micropreparative separation tools for bioanalysis. Our specific goal now is the development of an integrated discovery platform for a comprehensive, global view of differential protein expression. We will study and advance the newly introduced """"""""shot-gun"""""""" approaches to protein expression analysis (ICAT), using the following or a related sequence of steps: prefractionation of two proteomes separately, isotopic labeling, digestion, pooling, and separation/MS analysis. We shall develop novel chemistries and microfabricated separation tools for this effort. For prefractionation, we will focus on solution IEF in the form of a series of chambers with immobiline pH control on membranes separating the chambers or coated on the walls of the chambers. The former will be used for large scale protein prefractionation (10-50 mg) for low copy number expression and the latter for multiple chambers of 30 muL each in volume for high throughput and narrow pI range prefractionation. With respect to the chemistries to be employed, besides sulfhydryl reaction, we will use isotopic labeling of phosphate and N-terminal residues, the latter for comprehensive labeling of peptide fragments. Affinity approaches will be used in the analysis of glycosylation. The separation and mass spectroscopic analysis of the thousands of peptides will be accomplished using microfabricated multichannel 1 and 2 dimensional (LC/CE) high throughput separation devices, coupled off-line to MALDI targets. The resultant separation streaks will be analyzed by a very high throughput MALDI/TOF instrument (2k Hz laser) (being developed on another NIH grant). Novel microfabricated structures will be developed for separation, liquid pumping, automated sample loading, etc. We will use standard yeast samples to develop the technology, followed by relevant proteome samples, as provided by our collaborators. The various chemistries and separation devices will be integrated into discovery of global protein expression patterns in various relevant biological states.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM015847-33
Application #
6643410
Study Section
Special Emphasis Panel (ZRG1-BECM (01))
Program Officer
Edmonds, Charles G
Project Start
1978-12-01
Project End
2005-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
33
Fiscal Year
2003
Total Cost
$407,635
Indirect Cost
Name
Northeastern University
Department
Type
Organized Research Units
DUNS #
001423631
City
Boston
State
MA
Country
United States
Zip Code
02115
Li, Siyang; Plouffe, Brian D; Belov, Arseniy M et al. (2015) An Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood. Mol Cell Proteomics 14:1672-83
Liu, Zhenke; Dai, Shujia; Bones, Jonathan et al. (2015) A quantitative proteomic analysis of cellular responses to high glucose media in Chinese hamster ovary cells. Biotechnol Prog 31:1026-38
Li, Siyang; Nakayama, Tomoko; Akinc, Akin et al. (2015) Development of LC-MS methods for quantitation of hepcidin and demonstration of siRNA-mediated hepcidin suppression in serum. J Pharmacol Toxicol Methods 71:110-9
Panikov, Nicolai S; Mandalakis, Manolis; Dai, Shujia et al. (2015) Near-zero growth kinetics of Pseudomonas putida deduced from proteomic analysis. Environ Microbiol 17:215-28
Olsen, Lars; Campos, Benito; Winther, Ole et al. (2014) Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas. BMC Med Genomics 7 Suppl 3:S2
Brazin, Kristine N; Mallis, Robert J; Li, Chen et al. (2014) Constitutively oxidized CXXC motifs within the CD3 heterodimeric ectodomains of the T cell receptor complex enforce the conformation of juxtaposed segments. J Biol Chem 289:18880-92
Laviolette, Laura A; Wilson, Jonas; Koller, Julia et al. (2013) Human folliculin delays cell cycle progression through late S and G2/M-phases: effect of phosphorylation and tumor associated mutations. PLoS One 8:e66775
Li, Chen; Rossomando, Anthony; Wu, Shiaw-Lin et al. (2013) Comparability analysis of anti-CD20 commercial (rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches. MAbs 5:565-75
Dai, Shujia; Ni, Wenqin; Patananan, Alexander N et al. (2013) Integrated proteomic analysis of major isoaspartyl-containing proteins in the urine of wild type and protein L-isoaspartate O-methyltransferase-deficient mice. Anal Chem 85:2423-30
Tummala, Seshu; Titus, Michael; Wilson, Lee et al. (2013) Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals. Biotechnol Prog 29:415-24

Showing the most recent 10 out of 47 publications